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Summary
Recently, it has been demonstrated that the opportu-
nistic fungal pathogen Cryptococcus neoformans
can synthesize authentic immunomodulatory pro-
staglandins. The mechanism by which this takes
place is unclear as there is no cyclooxygenase homo-
logue in the cryptococcal genome. In this study, we
show that cryptococcal production of both PGE2 and
PGF2a can be chemically inhibited by caffeic acid,
resveratrol and nordihydroguaiaretic acid. These
polyphenolic molecules are frequently used as inhibi-
tors of lipoxygenase enzymes; however, BLAST
searches of the cryptococcal genome were unable to
identify any homologues of mammalian, plant or
fungal lipoxygenases. Next we investigated crypto-
coccal laccase, an enzyme known to bind polyphe-
nols, and found that either antibody depletion or
genetic deletion of the primary cryptococcal laccase
(lac1D) resulted in a loss of cryptococcal prostaglan-
din production. To determine how laccase is involved,
we tested recombinant laccase activity on the pros-
taglandin precursors, arachidonic acid (AA), PGG2
and PGH2. Using mass spectroscopy we determined
that recombinant Lac1 does not modify AA or PGH2,
but does have a marked activity toward PGG2 convert-
ing it to PGE2 and 15-keto-PGE2. These data demon-
strate a critical role for laccase in cryptococcal
prostaglandin production, and provides insight into a
new and unique fungal prostaglandin pathway.
Introduction
The production of oxidized fatty acids (oxylipins) from
single-celled eukaryotes is an emerging area of research
that has defined new mechanisms by which these or-
ganisms sense environment and community structure,
signal morphological differentiation and regulate virulence
(Noverr et al., 2003a; Erb-Downward and Huffnagle,
2006; Shea and Del Poeta, 2006; Tsitsigiannis and Keller,
2007). Among these discoveries is evidence that many
fungi are capable of producing 20-carbon oxylipins known
as prostaglandins (Noverr et al., 2002; Tsitsigiannis et al.,
2005a). In particular, Cryptococcus neoformans and
Candida albicans have been identified as capable of pro-
ducing authentic prostaglandin-E2 (PGE2) (Erb-Downward
and Huffnagle, 2007; Erb-Downward and Noverr, 2007), a
potent signalling molecule that can regulate inflammation
in higher eukaryotes (Harris et al., 2002).
Prostaglandins are 20-carbon fatty acid metabolites of
arachidonic acid (AA). In higher eukaryotes, the synthesis
of prostaglandins is dependent upon the action of
cyclooxygenase enzymes which first generate the
common precursor of prostaglandin synthesis, PGH2
(Smith et al., 2000). This precursor is then converted to
the various prostaglandins by the action of prostaglandin
synthases. The absolute dependence of prostaglandin
synthesis in higher eukaryotes upon a cyclooxygenase
has led to a biochemical paradox in that there is no
cyclooxygenase homologue in either the C. neoformans
or C. albicans genome (Tsitsigiannis et al., 2005b; Erb-
Downward and Huffnagle, 2007; Erb-Downward and
Noverr, 2007) and classical inhibitors of prostaglandin
synthesis, which are known to broadly inhibit cyclooxyge-
nases, do not inhibit prostaglandin synthesis (Erb-
Downward and Huffnagle, 2007; Erb-Downward and
Noverr, 2007). Recently, a family of fatty acid dioxygenase
enzymes (PpoA, PpoB and PpoC) which possess homol-
ogy to the catalytic domains of mammalian cyclooxyge-
nases were identified in Aspergillus nidulans and
Aspergillus fumagatis (Tsitsigiannis et al., 2005b). Further
analysis showed that the cultures produced prostaglan-
dins (as detected by immunoassay) and ppo mutants
produced less (Tsitsigiannis et al., 2005a). But these
enzymes do not exist in the C. neoformans genome
(Tsitsigiannis et al., 2005b). The current work details our
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investigation into the enzymes involved in cryptococcal
prostaglandin synthesis, and the discovery that a crypto-
coccal laccase is required for prostaglandin synthesis in
C. neoformans.
Results
Chemical inhibition of cryptococcal prostaglandin
synthesis
To examine the effects of chemical inhibition on crypto-
coccal prostaglandin production we first established a
lysate system by which multiple species of prostaglandins
could be measured. Briefly, lysates were generated
through mechanical disruption of stationary phase
C. neoformans cells followed by a 2 h incubation with
AA. Figure 1 demonstrates that multiple prostaglandin
species can be efficiently generated using this method
including PGF2a and PGE2. These also can be measured
using a pan-specific prostaglandin immunoassay that
detects multiple prostaglandin species (Fig. 1A). In this
lysate system, proportionally more PGF2a is synthesized
(Fig. 1C) than PGE2 (Fig. 1B). Furthermore, production
of prostaglandins is an enzymatic process (i.e. heat
denaturable), because boiling of the lysates prior to incu-
bation with AA results in a significant reduction in prostag-
landin production.
As we have previously demonstrated that cyclooxyge-
nase enzymes are not present in C. neoformans (Erb-
Downward and Huffnagle, 2007), we investigated whether
other classes of oxygenases could be involved by using
the inhibitors resveratrol, caffeic acid and nordihydroguai-
aretic acid (NDGA) to inhibit prostaglandin synthesis
in cell-free lysates. Caffeic acid (Fig. 2B) and NDGA
(Fig. 2A) are well characterized for their ability to inhibit
lipoxygenase enzymes (Koshihara et al., 1984; Salari
et al., 1984; Whitman et al., 2002; Tanaka et al., 2003)
whereas resveratrol (Fig. 2A), which shares a similar
structure, inhibits both cyclooxygenase and lipoxygenase
enzymes (Kimura et al., 1985; Kimura et al., 1995; Pinto
et al., 1999; Tanaka et al., 2003). All of the polyphenols
tested significantly decreased the total prostaglandin
production (Fig. 2). For resveratrol and NDGA, the inhibi-
tion was equivalent to boiling the lysates prior to the
addition of AA. These findings indicate that polyphenols
are capable of inhibiting cryptococcal prostaglandin
production.
BLAST searches of the cryptococcal genome for homo-
logues of 5-, 12- or 15-lipoxygenases from humans, mice
or rats did not reveal a lipoxygenase homologue (data not
shown). Similarly, searches for homologues of plant
lipoxygenases (1-LO from soy-beans, and 13-LO from
Arabidopsis thaliana) did not yield any protein with signifi-
cant homology. Even the 1-lipoxygenase found in the
fungus Neurospora crassa does not have a homologue in
C. neoformans (data not shown). Thus, we shifted our
focus from lipoxygenases and cyclooxygenases to other
enzymes known to interact with polyphenols (Li et al.,
2005).
Fig. 1. Prostaglandin production in cryptococcal lysates.
C. neoformans cells were lysed and the lysates incubated  AA for
2 h at 37°C. C. neoformans (C.neo) lysates were incubated with AA
and total prostaglandins were measured using a prostaglandin
screening EIA (A: n = 11; *P < 0.001); PGE2 were levels assayed
using a PGE2 monoclonal EIA (B: n = 7; *P < 0.001); and PGF2a
levels were assayed using a PGF2a monoclonal EIA (C: n = 5;
*P < 0.001).
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A role for laccase in cryptococcal prostaglandin
production
Cryptococcal laccase (lac1) is a multicopper oxidoreduc-
tase having a broad specificity that includes Fe(II), ami-
nophenols and polyphenols (Williamson, 1994; Liu et al.,
1999). Additionally, we have previously noted that growth
conditions that promote prostaglandin expression also
result in increased levels of prostaglandin production
(Noverr et al., 2001). To test whether this polyphenol-
binding enzyme plays a role in cryptococcal prostaglandin
synthesis, lysates were depleted of laccase prior to incu-
bation with AA by the addition of a monoclonal antibody
(G3P4D3) raised against the N-terminal portion of crypto-
coccal laccase. The laccase-depleted supernatants were
then incubated with AA, and prostaglandin levels were
measured by enzyme immunoassay (EIA; Fig. 3A).
Lysates treated with control antibody produced prostag-
landins at the same levels as untreated lysates. However,
immunoprecipitation of laccase from cryptococcal lysates
significantly diminished the ability of the lysates to
produce prostaglandins from AA.
Recently, a second laccase gene (LAC2) was identified
that shares 65% identity with LAC1 at the nucleotide level
(Zhu and Williamson, 2004). Sequence analysis suggests
that the mAb directed against the protein product of LAC1
might also recognize the product of LAC2. To assess the
relative contribution of each of these enzymes to crypto-
coccal prostaglandin production, LAC1 and LAC2 deletion
strains were incubated in the presence of exogenous AA,
the prostaglandins purified from the supernatants using
organic extraction followed by Reverse-phase high-
Fig. 2. The effect of inhibitors on total prostaglandin production
from C. neoformans lysates C. neoformans (C.neo) cells were
lysed, the lysates incubated  AA for 2 h at 37°C and total
prostaglandin production was measured using a prostaglandin
screening EIA. (A) and (B) document the effect of various
polyphenols on cryptococcal prostaglandin production. The results
are normalized as a per cent inhibition (where the lysate + AA was
set to 100%; A: n = 5 and B: n = 2; *P < 0.001).
Fig. 3. The effect of the removal of laccase on cryptococcal
prostaglandin production.
A. The effect of the immunoprecipitation (IP) of laccase from
cryptococcal lysates prior to the addition of AA. Inhibitory effect
is displayed as a per cent of control (the non-immunodepleted
lysate + AA), which was set to 100% (n = 4; *P < 0.001).
B. The effect of deleting the cryptococcal laccase genes on
prostaglandin production into culture (when incubated with AA).
Culture supernatants were taken from wild-type C. neoformans,
lac1D or lac2D strains that had been incubated for 2 h at 37°C in
the presence of AA. Fungal prostaglandins were extracted from the
culture supernatant into ethyl acetate and purified using RP-HPLC.
Total prostaglandins were measured by EIA (n = 2; *P < 0.05).
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performance liquid chromatography (RP-HPLC) fraction-
ation, and the levels assayed by EIA (Fig. 3B). The
LAC2-deficient strain produced the same levels of pros-
taglandins as the wild-type strain upon the addition of AA.
However, consistent with the lysate immunodepletion
experiments, the LAC1-deficient strain of C. neoformans
produced significantly lower levels of prostaglandins.
Thus, loss of LAC1, but not LAC2, decreases cryptococ-
cal prostaglandin production
We next investigated how Lac1 is involved in prostag-
landin synthesis. To address the question, recombinant
Lac1 was tested for whether prostaglandins or intermedi-
ates in prostaglandin synthesis could be generated from
AA, PGG2 or PGH2. If Lac1 functions as a cyclooxygenase,
PGG2 and PGH2 should be generated from AA. Alterna-
tively, if the activity of Lac1 is similar to a prostaglandin
synthase, then Lac1 should convert PGH2 to individual
prostaglandin species such as PGE2 or PGF2a. To this end,
increasing concentrations of recombinant Lac1 (rLac)
were incubated with 50 mM of substrate (AA, PGG2 or
PGH2) at 37°C for 3 h. The products were then extracted
into ethyl acetate (EtOAc), dried down and analysed by
tandem liquid chromatography-mass spectroscopy. Incu-
bation of rLac with either AA or PGH2 alone did not result in
the generation of new prostaglandins (data not shown).
However, increasing amounts of rLac incubated with
50 mM PGG2 resulted in a dose-dependent decrease in
PGG2 and a concomitant increase in PGE2 (Fig. 4). Thus,
Fig. 4. The effect of recombinant Lac1 on
PGG2 to PGE2 conversion. Increasing
concentrations of rLac1 were incubated with
PGG2, and the products were separated and
analysed using LC-MS as described in
Experimental procedures.
A. The extracted ion chromatograms of PGE2
(m/z range = 351–352 [M-H]– ion) and PGG2
(m/z range = 367–368 [M-H]– ion) with
increasing concentrations of rLac1. The
numbers above each peak denote the area
under the peak.
B. The increase in PGE2 production over
background levels and the decrease in PGG2.
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Lac1 does not carry out the cyclooxygenase reaction or
convert PGH2 to a prostaglandin like a prostaglandin syn-
thase, but it does possess a unique activity catalyzing the
conversion of PGG2 to PGE2.
In addition to PGE2, several other peaks within the m/z
range of 340–370 were notably different in the samples
that contained PGG2 +rLac when compared with those
that contained PGG2 alone. The most significant of these
occurred with an elution time of 11.3 min and possessed a
m/z = 349 [M-H]–. Using R-package XCMS (Smith et al.,
2006) and the METLIN database (http://metlin.scripps.
edu/) we were able to narrow down the possible related
compounds to PGE3, 15-keto-PGE2 and PGK2. Commer-
cial standards of these compounds were obtained and
assessed by LC-MS. Based on retention times, MS and
MS2 this peak was identified as the PGE2 metabolite
15-keto-PGE2 (Fig. 5). Thus, while Lac1 did not form the
endocyclic peroxide that a cyclooxygenase generates,
Lac1 carries out the unique conversion of PGG2 to PGE2
and 15-keto-PGE2 which clearly distinguishes it from a
prostaglandin synthase.
Discussion
Cryptococcus neoformans can synthesize authentic PGE2
that is identical to mammalian PGE2; however, this
Fig. 5. The effect of recombinant Lac1 on 15-keto-PGE2 levels. Chromatograms of samples containing 15-keto-PGE2 standard (A) or
PGG2  1000 U recombinant Lac1 (B) focusing on the m/z range = 349.1–349.5. Panel insets indicate the parent [M-H]- ion mass and MS2 of
this ion.
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process proceeds via unique enzymatic pathways which
do not involve a cyclooxygenase enzyme (Erb-Downward
and Huffnagle, 2007). We have identified the
C. neoformans laccase Lac1 as a critical enzyme in this
new pathway based on evidence that either the depletion
or disruption of Lac1 all but eliminates specific cryptococ-
cal prostaglandin production, and that the recombinant
enzyme can convert PGG2 to PGE2 and 15-keto-PGE2. In
addition to Lac1, these studies demonstrate that there are
likely at least two other enzymes in the cryptococcal pros-
taglandin pathway: one upstream of Lac1 activities and
the other downstream. The evidence for the existence of
the upstream enzyme is that cryptococcal lysates can
produce prostaglandins from exogenous AA, but Lac1 can
only produce prostaglandins from PGG2, an oxidized
product of AA. Similarly, the lysate data indicate that in
addition to PGE2, cryptococcal lysates supplemented with
exogenous AA synthesize PGF2a, but if Lac1 is removed
from the system the enzymatic production of PGE2
and PGF2a ceases. However, Lac1 does not synthesize
PGF2a, indicating that another enzyme must act on the
products of Lac1 to synthesize PGF2a. Together, these
data indicate that the cryptococcal prostaglandin pathway
is unique not only in the enzymes involved, but also the
structure of the pathway, which the evidence suggests is
linear. This clearly differentiates it from the common pre-
cursor model that is seen in cyclooxygenase-dependent
prostaglandin production (Fig. 6).
The demonstration that cryptococcal laccase is critical
to the production of cryptococcal prostaglandins provides
the first association between a laccase and prostaglandin
synthesis. Classically, laccases are thought of as
enzymes involved in the oxidation of polyphenols or the
degradation of plant lignin (Leonowicz et al., 2001). In
C. neoformans, laccase catalyses the formation of a
polymer melanin from 2,4- or 3,5-dihydroxy polyphenolic
precursors. Melanin, in turn, enhances the ability of the
organism to survive the oxidative burst within a macroph-
age and ultraviolet radiation induced damage out in the
environment (Gomez and Nosanchuk, 2003). However,
recent lines of study have begun to explore the action of
this class of enzymes on non-polyphenolic molecules
(Casa et al., 2003). In one report investigators studied the
ability of a mushroom laccase to degrade olive oil mill
waste effluents, a mixture of polyphenols, fatty acids and
other compounds. They found that in addition to polyphe-
nols, fatty acids were also oxidized by this enzyme (Karls-
son et al., 2001). Further study revealed that the oxidation
of long-chain poly-unsaturated fatty acids by the mush-
room laccase was specific and proceeded via a mecha-
nism that was remarkably similar to that of a lipoxygenase
(Zhang et al., 2002). A recent study comparing enzymes
from different organisms that, based on DNA sequence
homology, are considered laccases, found that many
members of the family do not possess the ability to
degrade lignin or oxidize polyphenols (Valderrama et al.,
2003). This suggests that alternative activities for this
enzyme might be more common than was previously
believed. Our studies provide additional support for the
activity of laccase enzymes beyond the oxidation of
polyphenolic compounds and lignin degradation: the gen-
eration of oxylipins from poly-unsaturated fatty acids.
In recent years much has been discovered about the
critical importance of lipid mediators in single-celled
eukaryotic pathogens. These effects include the stimula-
tion or inhibition of sexual development (depending on the
mediator), quorum sensing and the regulation of virulence
(Angeli et al., 2001; Noverr and Huffnagle, 2004; Tsitsi-
giannis et al., 2005a; Tsitsigiannis and Keller, 2006; Erb-
Downward and Noverr, 2007; Tsitsigiannis and Keller,
2007). Some of the prostaglandin production in these
organisms is attributable to the presence of a cyclooxy-
genase homologue (Tsitsigiannis et al., 2005a). However,
there also exists a body of literature relating to prostag-
landin production in non-vertebrate organisms that has
attempted to fit, unsuccessfully, what is found in these
organisms into model of cyclooxygenase-dependent
prostaglandin production (reviewed in Lamacka and Saj-
bidor, 1995; Noverr et al., 2003a). Recent studies have
examined Trypanosoma brucei, Trypanosoma cruzii and
Plasmodium falciparum, in the absence of a host, and
found that they produce prostaglandins that are not inhib-
ited by aspirin or indomethacin (Kilunga Kubata et al.,
1998; Kubata et al., 2000; 2002). This production also
occurs in the absence of an identifiable cyclooxygenase
enzyme. In these organisms, a PGF2a synthase has been
identified which is homologous to the Old Yellow enzyme
found in Saccharomyces cerevisiae (Kubata et al., 2000;
2002). It has also been reported that the parasite-derived
prostaglandins of Schistosoma mansoni actively sup-
press the immune system to facilitate infection of the host
(Herve et al., 2003). PGE2 is well known for its ability to
suppress inflammation (Harris et al., 2002), and 15-keto-
PGE2 has been recently identified as a ligand for PPARg
(Chou et al., 2007), a nuclear receptor involved in the
regulation of macrophage activation. Thus, it is tempting
to speculate that cryptococcal production of prostaglan-
dins may help downregulate local inflammatory re-
sponses. The recent finding that cryptococcus carries out
its sexual cycle in association with plants (Xue et al.,
2007) is another area where these oxylipins may be
involved since oxylipin regulation of sexual cycles of other
fungi has been well established (Tsitsigiannis et al.,
2005b; Tsitsigiannis and Keller, 2006; Tsitsigiannis and
Keller, 2007). To date only two enzymes involved in cryp-
tococcal prostaglandin synthesis have been identified:
phospholipase B (PLB; Cox et al., 2001; Noverr et al.,
2003b) and now laccase (Lac1). Both are known virulence
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factors and the currently proposed mechanisms of viru-
lence do not account for their role in prostaglandin
synthesis. It is our belief that as additional enzymes
involved in cryptococcal prostaglandin synthesis are dis-
covered, the contribution of prostaglandins to the patho-
genesis of C. neoformans will likely become clear.
Experimental procedures
Strains and culture conditions
Throughout this study, C. neoformans strain 24067 was used
except where C. neoformans deletion mutants were used.
For these latter studies, the LAC1 deletion mutant (lac1D),
Fig. 6. The common precursor versus a
linear model of cryptococcal prostaglandin
synthesis.
A. The common precursor model of
prostaglandin synthesis where
cyclooxygenase enzymes act on free
arachidonic acid to produce PGH2, which then
serves as the common substrate for the
individual prostaglandin synthases.
B. The proposed linear model of cryptococcal
prostaglandin synthesis, where each step is
dependent upon the product of the step
before. Question marks denote steps where
the enzymes are not yet known, or a likely
candidate whose activity has yet to be
demonstrated.
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the LAC2 deletion mutant (lac2D) and the parent strain (H99)
were utilized (Zhu and Williamson, 2004). All strains were
grown shaking at ~37°C in 30 ml Sabouraud dextrose broth
(1% neopeptone and 2% dextrose; Difco, Detroit, MI) until
stationary phase was reached (72 h or until the cells reached
a concentration > 2 ¥ 108 ml-1).
C. neoformans lysis protocol
A total of 1.2 ¥ 109 cells were transferred to a 50 ml conical
tube, spun down at 3000 r.p.m. and washed 2¥ with 40 ml
sterile saline. Next, 1.2 ml of cold phosphate buffer (pH 7.1)
was added to the tube without disturbing the pellet. This was
followed by the addition of 0.5 mm glass beads until the beads
just began to dry. The tube was then subjected to a vigorous
regimen of vortexing 5¥ for 1 min followed by 1 min on ice.
The liquid was then transferred to another tube, and the
beads washed 2¥ with 600 ml cold phosphate buffer, vortex-
ing and transferring the liquid portion with each wash. This
crude lysate was then spun down at 13 000 r.p.m. for 45 min
to remove debris and unlysed cells. From these tubes the
supernatant (lysate) was transferred to a fresh 15 ml conical
and kept on ice.
Prostaglandin production and measurement
Prostaglandins were generated from cryptococcal lysates by
incubating 150 ml of lysate in a 1.5 ml Eppendorf tube with
500 mM AA (Cayman Chemical) at 37°C for 2 h. The require-
ment for functional enzymes was tested by boiling a portion of
C. neoformans lysate for 10 min followed by spinning down
the precipitated proteins prior to the addition of AA. The
lipoxygenase inhibitors caffeic acid and NDGA (Cayman
Chemical) and resveratrol (Sigma Chemical) were dissolved
in DMSO. Inhibition studies were performed by adding inhibi-
tor or an equivalent amount of DMSO to lysate samples just
prior to incubation with AA.
Prostaglandins were generated in whole-cell supernatants
by incubating 1 ¥ 107 cells in 1 ml phosphate buffer, pH 7.1,
with 500 mM AA or control at 37°C for 2 h. Following incuba-
tion, the cells were spun down and the supernatant removed
and assayed for prostaglandin content.
Prostaglandins were measured utilizing PGE2 specific,
PGF2a specific or the Prostaglandin Screening EIA (Cayman
Chemical) according to manufacturer’s protocols. EIA plates
were read at 405 nm, and the concentrations of prostaglandin
were calculated based on a bound versus free (B/B0)
measurement. Background values in the absence of lysate
were subtracted from each corresponding sample condition
to obtain a specific measurement of prostaglandin production
owing to the conversion of AA.
Organic extraction and reverse-phase HPLC
To assay the organic compounds produced in cryptococcal
supernatants, samples were transferred to a silianized
12 ¥ 75 cm glass test tube, the organic components
extracted twice into 500 ml HPLC grade EtOAc (Aldrich
Chemical), and the organic phase transferred to a silianized
conical screw-top vial. The contents of the vial were dried
down in a water bath under a stream of grade 5 nitrogen.
Reverse-phase high-performance liquid chromatography
analysis was carried out using a Waters 600 HPLC
system, with a 5 ml sample loop and a Waters Symmetry
2.1 ¥ 150 mm analytical column. The compounds were
separated using a gradient elution starting at 75:25:0.1
(water : acetonitrile : acetic acid) for 10 min followed by a
linear shift to 0:100:0.1 (water : acetonitrile : acetic acid) over
75 min. The dry sample was brought up in 25 ml HPLC grade
EtOH, and 12.5 ml was (5 ml) injected. The remainder was
dried down under nitrogen and stored at -20°C for not longer
than 1 week. Fractions were collected, and the organic com-
pounds were once again extracted twice into 500 ml EtOAc,
followed by drying down under nitrogen. These samples were
then brought up in 150 ml prostaglandin EIA buffer (Cayman
Chemical) and assayed according to manufacturer’s proto-
cols as above.
The elution times of cyclooxygenase-derived prostaglandin
standards (Cayman Chemical) were obtained using the same
elution gradient.
Purified enzyme studies
The recombinant Lac1 used in these studies was generated
as previously described (Zhu et al., 2001). Lyophilized
recombinant Lac1 (rLac) was reconstituted in 50 mM phos-
phate buffer pH 6.5. Enzyme activity was determined by
adding 1 ml of rLac to 1 ml of 1 mM epinephrine bitartrate for
30 min at 37°C and measuring the absorbance at 475 nm.
One unit of enzyme activity was equal to change of 0.001 AU.
To test rLac activity on prostaglandin relevant substrates 100,
500 or 1000 U of rLac was added to 50 mM AA or PGG2 in a
30 ml reaction volume for 3 h at 37°C. Reactions were
stopped by the addition of 150 ml of EtOAc, the organic phase
was removed and dried down under N2.
LC-MS/MS was carried out using a ThermoFinnigan Sur-
veyor HPLC (San Jose, CA) interfaced directly to the elec-
trospray ionization source of a ThermoFinnigan LTQ linear
ion-trap mass spectrometer (San Jose, CA). Samples were
re-suspended in a methanol : water solution (1:1, v/v) and
20 ml aliquots were injected onto a Phenomenex Luna
2.00 ¥ 150 mm 3 mm C-18(2) column (Torrence, CA). Mobile
phase solvents were water + 0.1% acetic acid (A) and
acetonitrile + 0.1% acetic acid (B). Compounds were sepa-
rated and eluted from the analytical column with a linear
gradient of 25–100% B over 40 min at a flow rate of
0.3 ml min-1. The sample tray was cooled to 4°C throughout
the analysis. Concentrations of compounds were calculated
by taking the ratio of area of peak to the area of the internal
standard peak (15-deoxy-D12,14-PGJ2) and multiplying by the
response factor. The response factor was calculated as a
ratio of the peak areas of known concentrations of commer-
cial standards of PGG2, 15-keto-PGE2 and PGE2 to the peak
area of a 1 mg ml-1 15-deoxyD12,14-PGJ2.
Immunoprecipitation
Immunoprecipitation of laccase from cryptococcal lysates
was carried out by incubating 600 ml lysates on ice with
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15 mg ml-1 anti-laccase mouse monoclonal antibody (clone
G3P4D3) raised against full-length recombinant laccase
enzyme or control mouse IgG, for 2 h on ice prior to the
addition of 50 ml of protein-A beads (Sigma). Tubes were set
to rock overnight at 4°C and the following day, beads were
spun down at 13 000 r.p.m. for 1 min and the supernatant
transferred to a fresh tube. This depleted lysate was then
treated as above to generate prostaglandins.
Statistical analysis
Statistical analysis of results was performed using Prism 4.0
(GraphPad Software). Statistical significance was deter-
mined using either a one-way ANOVA with Bonferroni’s mul-
tiple comparison post-test. For the purposes of comparing the
degree of inhibition of the various inhibitors, the data were
represented as a percentage of control (Lysate + AA).
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